Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Postnovo: Post-Processing De Novo Peptide Sequences

ABSTRACT: See paper: Postnovo: Post-Processing Improves the Accuracy of De Novo Peptide Sequences

INSTRUMENT(S): LTQ Orbitrap Elite

ORGANISM(S): Synechococcus Sp. Wh 7803 (ncbitaxon:32051) Desulfovibrio Vulgaris Str. Hildenborough (ncbitaxon:882) Escherichia Coli K-12 (ncbitaxon:83333) Rhodopseudomonas Palustris Tie-1 (ncbitaxon:395960)

SUBMITTER: Jacob Waldbauer

PROVIDER: MSV000082266 | MassIVE | Tue Apr 10 15:59:00 BST 2018

SECONDARY ACCESSION(S): PXD009462

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

Application of de novo sequencing to large-scale complex proteomics datasets

Project description:Dependent on concise, pre-defined protein sequence databases, traditional search algorithms perform poorly when analyzing mass spectra derived from wholly uncharacterized protein products. Conversely, de novo peptide sequencing algorithms can interpret mass spectra without relying on reference databases. However, such algorithms have been difficult to apply to complex protein mixtures, in part due to a lack of methods for automatically validating de novo sequencing results. Here, we present novel metrics for benchmarking de novo sequencing algorithm performance on large scale proteomics datasets, and present a method for accurately calibrating false discovery rates on de novo results. We also present a novel algorithm (LADS) which leverages experimentally disambiguated fragmentation spectra to boost sequencing accuracy and sensitivity. LADS improves sequencing accuracy on longer peptides relative to other algorithms and improves discriminability of correct and incorrect sequences. Using these advancements, we demonstrate accurate de novo identification of peptide sequences not identifiable using database search-based approaches.

2016-01-12 | PXD003317 | Pride

Multienzyme deep learning models improve peptide de novo sequencing by mass spectrometry proteomics

Project description:Generating and analyzing overlapping peptides through multienzymatic digestion is an efficient procedure for de novo protein using from bottom-up mass spectrometry (MS). Despite improved instrumentation and software, de novo MS data analysis remains challenging. In recent years, deep learning models have represented a performance breakthrough. Incorporating that technology into de novo protein sequencing workflows require machine-learning models capable of handling highly diverse MS data. In this study, we analyzed the requirements for assembling such generalizable deep learning models by systematically varying the composition and size of the training set. We assessed the generated models' performances using two test sets composed of peptides originating from the multienzyme digestion of samples from various species. The peptide recall values on the test sets showed that the deep learning models generated from a collection of highly N- and C-termini diverse peptides generalized 76% more over the termini-restricted ones. Moreover, expanding the training set's size by adding peptides from the multienzymatic digestion with five proteases of several species samples led to a 2-3 fold generalizability gain. Furthermore, we tested the applicability of these multienzyme deep learning (MEM) models by fully de novo sequencing the heavy and light monomeric chains of five commercial antibodies (mAbs). MEMs extracted over 10000 matching and overlapped peptides across six different proteases mAb samples, achieving a 100% sequence coverage for 8 of the ten polypeptide chains. We foretell that the MEMs' proven improvements to de novo analysis will positively impact several applications, such as analyzing samples of high complexity, unknown nature, or the peptidomics field.

2023-01-16 | PXD037803 | Pride

de novo methylation by Clr4

Project description:To investigate the role of de novo methylation by Clr4, we performed the reintroduction of Clr4 and ecopic insertion of lnc230

2024-01-01 | GSE223203 | GEO

De novo DNA methylation suppresses aberrant fate trajectory during epiblast transition [RNA-seq]

Project description:Genome remethylation is essential for mammalian development. Here we examined cell fate in the absence of de novo DNA methyltransferases. We found that embryonic stem (ES) cells deficient for Dnmt3a and Dnmt3b are rapidly eliminated from chimaeras. Pluripotency progression is derailed towards extra-embryonic trophoblast. This aberrant trajectory is propelled by failure to methylate and suppress expression of Ascl2 during formative transition. Ascl2 deletion rescues transition and improves contribution to chimaeric epiblast but mutant cells are progressively lost in later development. These findings indicate that methylation constrains transcriptome trajectories during developmental transitions by silencing potentially disruptive genes. This submission is RNA-seq.

2021-09-01 | GSE158310 | GEO

De novo DNA methylation suppresses aberrant fate trajectory during epiblast transition [ATAC-seq]

2021-09-01 | GSE158344 | GEO

Complete De Novo Assembly of Monoclonal Antibody Sequences.

Project description: Not available

| S-EPMC4999880 | biostudies-other

Disabling de novo DNA methylation in embryonic stem cells allows an illegitimate fate trajectory

Project description:Genome remethylation is essential for mammalian development but specific reasons are unclear. Here we examined embryonic stem (ES) cell fate in the absence of de novo DNA methyltransferases. We observed that ES cells deficient for both Dnmt3a and Dnmt3b are rapidly eliminated from chimeras. On further investigation we found that in vivo and in vitro the formative pluripotency transition is derailed toward production of trophoblast. This aberrant trajectory is associated with failure to suppress activation of Ascl2. Ascl2 encodes a bHLH transcription factor expressed in the placenta. Misexpression of Ascl2 in ES cells provokes transdifferentiation to trophoblast-like cells. Conversely, Ascl2 deletion rescues formative transition of Dnmt3a/b mutants and improves contribution to chimeric epiblast. Thus, de novo DNA methylation safeguards against ectopic activation of Ascl2. However, Dnmt3a/b-deficient cells remain defective in ongoing embryogenesis. We surmise that multiple developmental transitions may be secured by DNA methylation silencing potentially disruptive genes. This SuperSeries is composed of the SubSeries listed below.

2021-08-31 | GSE158347 | GEO

De novo copy number variations in cloned dogs (Nimblegen)

Project description:De novo copy number variations in cloned dogs from the same nuclear donor In this study, we aimed to identify de novo post-cloning CNV events and estimated the rate of CNV mosaicism in cloned dogs with the identical genetic background. We analyzed CNVs in seven cloned dogs using the nuclear donor genome as reference by array-CGH

2013-12-17 | E-GEOD-49092 | biostudies-arrayexpress

De novo designed cyclic-peptide heme complexes.

Project description: Not available

| S-EPMC263730 | biostudies-literature

Antimicrobial peptide capsids of de novo design.

Project description: Not available

| S-EPMC5741663 | biostudies-literature